why choose us

First received: October 26, 2022

Clinical Trial: Effect of Allopurinol on Markers of Mineral and Bone Metabolism

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Kidney Diseases

Study Type: INTERVENTIONAL


Official Title: Effect of Allopurinol on Markers of Mineral and Bone Metabolism in Patients in With Chronic Kidney Disease: a Randomized Double-blind Study

Brief Summary: Hyperuricemia is a common condition in patients with chronic kidney disease (CKD) in the glomerular filtration rate.Recently, it has been suggested that uric acid is related to a mineral and bone disease of CKD (CKD-MBD) since the high concentration of uric acid is associated with the harmful effect of vitamin D. The proof of concept of the association between acid uric acid and CKD-MBD is based on a prospective study (sample size 6) that observed, after 1 week of use of allopurinol, an increase in the…

Read more